Bridging cheminformatic metabolite prediction and tandem mass spectrometry

被引:33
作者
Anari, MR [1 ]
Baillie, TA [1 ]
机构
[1] Merck Res Labs, Dept Drug Metab, W Point, PA 19486 USA
关键词
D O I
10.1016/S1359-6446(05)03445-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite recent technological advances, the analysis of biological samples for metabolite identification purposes often requires prior knowledge of the metabolite masses to successfully acquire high quality mass spectral data in the presence of intense background and interfering matrix signals.. This, in turn, necessitates prior knowledge of the metabolite structure, which in most cases can be predicted on the basis of the potential routes of metabolism of those functional groups present in the molecule. The following discussion highlights the significance of knowledge of the metabolite mass in facilitating the detection and structural elucidation of drug metabolites.
引用
收藏
页码:711 / 717
页数:7
相关论文
共 58 条
[31]   Rapid drug metabolite profiling using fast liquid chromatography, automated multiple-stage mass spectrometry and receptor-binding [J].
Lim, HK ;
Stellingweif, S ;
Sisenwine, S ;
Chan, KW .
JOURNAL OF CHROMATOGRAPHY A, 1999, 831 (02) :227-241
[32]   Simultaneous screen for microsomal stability and metabolite profile by direct injection turbulent-laminar flow LC-LC and automated tandem mass spectrometry [J].
Lim, HK ;
Chan, KW ;
Sisenwine, S ;
Scatina, JA .
ANALYTICAL CHEMISTRY, 2001, 73 (09) :2140-2146
[33]  
Lin JH, 2002, E SCHERING RES FDN W, V37, P33
[34]   Matrix effect in quantitative LC/MS/MS analyses of biological fluids: A method for determination of finasteride in human plasma at picogram per milliliter concentrations [J].
Matuszewski, BK ;
Constanzer, ML ;
Chavez-Eng, CM .
ANALYTICAL CHEMISTRY, 1998, 70 (05) :882-889
[35]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY - ITS USE FOR THE IDENTIFICATION OF STANOZOLOL AND ITS MAJOR METABOLITES IN HUMAN AND EQUINE URINE [J].
MUCK, WM ;
HENION, JD .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (01) :37-51
[36]  
MUTLIB AE, 1995, DRUG METAB DISPOS, V23, P951
[37]  
MUTLIB AE, 2003, DRUG METABOLIZING EN, P33
[38]   Strategies for dealing with metabolite elucidation in drug discovery and development [J].
Nassar, AEF ;
Talaat, RE .
DRUG DISCOVERY TODAY, 2004, 9 (07) :317-327
[39]   Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction [J].
Nassar, AEF ;
Adams, PE .
CURRENT DRUG METABOLISM, 2003, 4 (04) :259-271
[40]   P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature [J].
Nelson, DR ;
Koymans, L ;
Kamataki, T ;
Stegeman, JJ ;
Feyereisen, R ;
Waxman, DJ ;
Waterman, MR ;
Gotoh, O ;
Coon, MJ ;
Estabrook, RW ;
Gunsalus, IC ;
Nebert, DW .
PHARMACOGENETICS, 1996, 6 (01) :1-42